“천안립카페🌇 〔OPdal040.COM◀오피달리기 💑천안건마🏮천안휴게텔😹천안마사지🗼천안스파🏅천안오피💪천안출장안마🐤”的搜索结果，显示 401-410 项，共有 15351 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Establish a prospective database of all patients with peritoneal surface malignancies seen by Dr. Travis Grotz at the Mayo Clinic, Rochester. Design and ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of documentation of HLA-A LOH status; The percentage ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of documentation of HLA-A LOH status; The percentage ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The primary purpose of the pilot study is to evaluate the safety and tolerability of an autologous dendritic cells (DC) vaccine delivered by intra-tumoral ...

6. 妙佑医疗国际 - CBD：安全有效？

   CBD 的益处是什么？使用是否安全？ 处方大麻二酚（CBD）油是一种有效的抗癫痫发作药物。然而，还需开展进一步研究 ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic leukemia that ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment. Despite not needing therapy, these patients ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of documentation of HLA-A LOH status; The percentage ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Jacksonville, Fla. This open-label, randomized study will compare the efficacy of GDC-0199 plus rituximab (GDC-0199+R) with bendamustine plus MabThera/Rituxan ( ...